lc model software concentration (Provencher Inc)
90
Structured Review
Provencher Inc
lc model software concentration
Lc Model Software Concentration, supplied by Provencher Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lc-model+software/lc+model+software+concentration/pmc11954936-82-46-51
Average 90 stars, based on 1 article reviews
Lc Model Software Concentration, supplied by Provencher Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lc-model+software/lc+model+software+concentration/pmc11954936-82-46-51
Average 90 stars, based on 1 article reviews
lc model software concentration - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
In Vivo:Article Title: Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb Article Snippet: In vivo MRS data were processed using the Article Title: Magnetic resonance spectroscopy of atypical diffuse pontine masses. Article Snippet: Proton spectra were processed using the LC-Model software (Stephen Provencher Inc., Oakville, ON, Canada). Article Title: Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes. Article Snippet: Objective: We recently investigated the effect of ipragliflozin, a sodium glucose co-transporter-2 inhibitor (SGLT-2I), in Japanese patients with type 2 diabetes by a 24-week.. SGLT-2Is also have an anti-obesity effect, and reduction of body fat has been demonstrated by indirect methods.. However, evaluation of the effect on the total visceral fat volume and intrahepatic lipid content has not been performed. Article Title: Primary Hyperparathyroidism: The Influence of Bone Marrow Adipose Tissue on Bone Loss and of Osteocalcin on Insulin Resistance Article Snippet: The spectra were processed with the Article Title: Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb Article Snippet: Data analysis In vivo MRS data were processed using the Article Title: Liraglutide Reduces Visceral and Intrahepatic Fat Without Significant Loss of Muscle Mass in Obese Patients With Type 2 Diabetes: A Prospective Case Series Article Snippet: Spectrum fitting and analysis were done with LC-Model software (version 6.2; S. Article Title: Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes. Article Snippet: Aims: To evaluate the effect of the DPP-4 inhibitor sitagliptin on intrahepatic lipid (IHL) content and body fat in overweight Japanese patients with type 2 diabetes.. Methods: A prospective, 24-week, single-center, open-label comparative study enrolled 20 Japanese patients with type 2 diabetes (male: 11, female: 9) with a BMI 25 kg/m or fatty liver.. Subjects were randomly assigned to receive treatment with sitagliptin (25 mg titrated up to 50 mg: S) or glimepiride (0.5 mg titrated up to 1 mg: G). Article Title: Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder. Article Snippet: Original Papers J Journal of Psychopharmacology 21(4) (2007) 435–439 © 2007 British Association for Psychopharmacology ISSN 0269-8811 SAGE Publications Ltd, Los Angeles, London, New Delhi and Singapore 10.1177/0269881106067787 Ethyl-eicosapentanoic acid (ethyl-EPA) may be beneficial in the treatment of bipolar disorder (BD) and may have a neurotrophic/neuroprotective role in patients with neuropsychiatric disorders.. To investigate this we examined whether ethyl-EPA treatment of BD patients is associated with increased brain levels of N-acetylaspartate (NAA), a putative marker of neuronal integrity.. Fourteen female BD outpatients with moderate depressive symptoms were administered 2g of ethyl-EPA per day or placebo for 12 weeks in a randomized, doubleblind fashion. Software:Article Title: Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb Article Snippet: In vivo MRS data were processed using the Article Title: Magnetic resonance spectroscopy of atypical diffuse pontine masses. Article Snippet: Proton spectra were processed using the LC-Model software (Stephen Provencher Inc., Oakville, ON, Canada). Article Title: Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes. Article Snippet: Objective: We recently investigated the effect of ipragliflozin, a sodium glucose co-transporter-2 inhibitor (SGLT-2I), in Japanese patients with type 2 diabetes by a 24-week.. SGLT-2Is also have an anti-obesity effect, and reduction of body fat has been demonstrated by indirect methods.. However, evaluation of the effect on the total visceral fat volume and intrahepatic lipid content has not been performed. Article Title: Primary Hyperparathyroidism: The Influence of Bone Marrow Adipose Tissue on Bone Loss and of Osteocalcin on Insulin Resistance Article Snippet: The spectra were processed with the Article Title: Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb Article Snippet: Data analysis In vivo MRS data were processed using the Article Title: Liraglutide Reduces Visceral and Intrahepatic Fat Without Significant Loss of Muscle Mass in Obese Patients With Type 2 Diabetes: A Prospective Case Series Article Snippet: Spectrum fitting and analysis were done with LC-Model software (version 6.2; S. Article Title: Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes. Article Snippet: Aims: To evaluate the effect of the DPP-4 inhibitor sitagliptin on intrahepatic lipid (IHL) content and body fat in overweight Japanese patients with type 2 diabetes.. Methods: A prospective, 24-week, single-center, open-label comparative study enrolled 20 Japanese patients with type 2 diabetes (male: 11, female: 9) with a BMI 25 kg/m or fatty liver.. Subjects were randomly assigned to receive treatment with sitagliptin (25 mg titrated up to 50 mg: S) or glimepiride (0.5 mg titrated up to 1 mg: G). Article Title: Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder. Article Snippet: Original Papers J Journal of Psychopharmacology 21(4) (2007) 435–439 © 2007 British Association for Psychopharmacology ISSN 0269-8811 SAGE Publications Ltd, Los Angeles, London, New Delhi and Singapore 10.1177/0269881106067787 Ethyl-eicosapentanoic acid (ethyl-EPA) may be beneficial in the treatment of bipolar disorder (BD) and may have a neurotrophic/neuroprotective role in patients with neuropsychiatric disorders.. To investigate this we examined whether ethyl-EPA treatment of BD patients is associated with increased brain levels of N-acetylaspartate (NAA), a putative marker of neuronal integrity.. Fourteen female BD outpatients with moderate depressive symptoms were administered 2g of ethyl-EPA per day or placebo for 12 weeks in a randomized, doubleblind fashion. |